Literature DB >> 8018041

Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements.

L F Scinto1, K R Daffner, L Castro, S Weintraub, M Vavrik, M M Mesulam.   

Abstract

OBJECTIVE: To investigate changes in spatially directed attention in patients with a diagnosis of probable Alzheimer's disease (AD).
BACKGROUND: Impaired attention in patients with probable AD has not been the subject of extensive research. Yet recent reports suggest that attentional deficits may be an important early feature of the disease in a subset of patients.
SETTING: University hospital center studying dementia and aging.
SUBJECTS: Ten mild to moderately impaired patients diagnosed as having probable AD, by National Institute of Neurologic and Communicative Diseases and Stroke criteria, and 11 healthy age- and education-matched controls. MEASURES: Eye movements were recorded as subjects participated in two experiments designed to measure spatially directed attention. Subjects were instructed to (1) attend to and fixate a target appearing randomly to the right or left of a central marker and (2) direct attention to and fixate a target appearing randomly in one of four peripheral locations.
RESULTS: Patients with probable AD exhibited fewer accurate trials and longer saccade latencies in both tasks. As a group, patients performed worse in the second task that placed increased demands on attention. However, the performance of patients in this second experiment varied. Four patients performed significantly worse than all other patients, while three patients performed as well as controls. Errors in the second task were reviewed to identify specific types of attentional deficits. Six empirically derived error patterns were classified into one of two major categories: perseveration and impersistence. Seven of 10 patients made greater than 50% errors of perseveration, and three of 10 made greater than 50% errors of impersistence.
CONCLUSIONS: Impairment of attention may be an early feature of AD and a prominent clinical characteristic of some patients. The differences observed in error types made by patients may reflect the varied distribution of neuropathologic changes affecting structures that mediate aspects of attention. The architecture of eye movements can be used as a physiologic measure that should provide useful information for the diagnosis and clinicopathologic subtyping of patients with AD.

Entities:  

Mesh:

Year:  1994        PMID: 8018041     DOI: 10.1001/archneur.1994.00540190062016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

Review 1.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

2.  Detecting cognitive impairment by eye movement analysis using automatic classification algorithms.

Authors:  Dmitry Lagun; Cecelia Manzanares; Stuart M Zola; Elizabeth A Buffalo; Eugene Agichtein
Journal:  J Neurosci Methods       Date:  2011-07-27       Impact factor: 2.390

Review 3.  The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.

Authors:  A D Lawrence; B J Sahakian
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 4.  Memory deficits in Alzheimer's disease: the encoding hypothesis and cholinergic function.

Authors:  K Geoffrey White; Angela C Ruske
Journal:  Psychon Bull Rev       Date:  2002-09

Review 5.  Eye movements in Alzheimer's disease.

Authors:  Robert J Molitor; Philip C Ko; Brandon A Ally
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Perception of Fechner Illusory Colors in Alzheimer Disease Patients.

Authors:  Gintaras Kaubrys; Vera Bukina; Ieva Bingelytė; Vladas Taluntis
Journal:  Med Sci Monit       Date:  2016-11-30

Review 7.  The apolipoprotein E gene, attention, and brain function.

Authors:  Raja Parasuraman; Pamela M Greenwood; Trey Sunderland
Journal:  Neuropsychology       Date:  2002-04       Impact factor: 3.295

Review 8.  Ocular motor abnormalities in neurodegenerative disorders.

Authors:  C A Antoniades; C Kennard
Journal:  Eye (Lond)       Date:  2014-11-21       Impact factor: 3.775

Review 9.  Prosaccade and Antisaccade Paradigms in Persons with Alzheimer's Disease: A Meta-Analytic Review.

Authors:  Naomi Kahana Levy; Michal Lavidor; Eli Vakil
Journal:  Neuropsychol Rev       Date:  2017-10-27       Impact factor: 7.444

Review 10.  Saccadic Eye Movement in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Julius Opwonya; Dieu Ni Thi Doan; Seul Gee Kim; Joong Il Kim; Boncho Ku; Soochan Kim; Sunju Park; Jaeuk U Kim
Journal:  Neuropsychol Rev       Date:  2021-05-06       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.